Product analysis
Hawthorn 525 mg offers a simple, inexpensive hawthorn supplement for people interested in heart support. The preparation is unspecified, so findings from particular extracts do not establish routine benefits from this version.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The hawthorn preparation is not identified clearly enough to judge its quality. Its stated amount does not establish equivalence to specific extracts with clinical findings.
Ingredient Transparency63
The hawthorn amount is stated, but its preparation is unspecified. That limits comparison with clearly identified extracts.
Value For Money100
The cost per labeled serving is low. That makes it inexpensive to buy, although affordability does not resolve uncertainty about the preparation’s benefits.
Customer Satisfaction85
Customer feedback is very positive across a large number of ratings. The broad review base strengthens the picture of satisfaction without establishing heart benefits.
Product Focus73
A single botanical keeps the formula focused on heart-related use. Findings for particular hawthorn extracts are mixed and do not establish routine benefits from this preparation.
- Format
Capsule - Container
- 100 VegCap(s)
- Per serving
- $0.20
- Also available
Hawthorn 1050 mg$18.06- Customer rating
- 4.7 · 2,114 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Hawthorn | 1050 mg |
How this ingredient is rated
Composition and Label Disclosure29
Marker and Preparation Disclosure
Species Name Disclosure
Composition and Label Disclosure
Commercial Price and Usability100
Commercial Price per Labeled Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
- Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
- A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
- [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
- Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
- [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
- Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
- Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
- Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.